Body composition of HIV/AIDS males

Effects of treatment with insulin- like growth factor (IGF-I) and growth hormone (GH)

K. J. Ellis, Phillip Lee, J. M. Pivarnik, J. G. Bukar, N. Gesundheit

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A study was conducted to determine whether a pharmacological dose of insulin-like growth factor (IGF-I), administered with a low dose of growth hormone (GH), could produce an anabolic response in HIV/AIDS patients. The minimum effective GH dose needed, however, is not known. The GH dose selected was about an order of magnitude lower than that usually used for pharmacological treatment of GH deficiency. It was found that the moderate IGF-I dose combined with a low GH dose was insufficient to produce a detectable anabolic response as judged by the measurements of total body potassium (TBK) and total body nitrogen (TBN).

Original languageEnglish (US)
Pages (from-to)653-655
Number of pages3
JournalApplied Radiation and Isotopes
Volume49
Issue number5-6
DOIs
StatePublished - May 1998
Externally publishedYes

Fingerprint

pituitary hormones
acquired immunodeficiency syndrome
insulin
human immunodeficiency virus
dosage
potassium
nitrogen

ASJC Scopus subject areas

  • Radiation

Cite this

Body composition of HIV/AIDS males : Effects of treatment with insulin- like growth factor (IGF-I) and growth hormone (GH). / Ellis, K. J.; Lee, Phillip; Pivarnik, J. M.; Bukar, J. G.; Gesundheit, N.

In: Applied Radiation and Isotopes, Vol. 49, No. 5-6, 05.1998, p. 653-655.

Research output: Contribution to journalArticle

@article{7ff7c5ea0af442c08a781e5d04efe881,
title = "Body composition of HIV/AIDS males: Effects of treatment with insulin- like growth factor (IGF-I) and growth hormone (GH)",
abstract = "A study was conducted to determine whether a pharmacological dose of insulin-like growth factor (IGF-I), administered with a low dose of growth hormone (GH), could produce an anabolic response in HIV/AIDS patients. The minimum effective GH dose needed, however, is not known. The GH dose selected was about an order of magnitude lower than that usually used for pharmacological treatment of GH deficiency. It was found that the moderate IGF-I dose combined with a low GH dose was insufficient to produce a detectable anabolic response as judged by the measurements of total body potassium (TBK) and total body nitrogen (TBN).",
author = "Ellis, {K. J.} and Phillip Lee and Pivarnik, {J. M.} and Bukar, {J. G.} and N. Gesundheit",
year = "1998",
month = "5",
doi = "10.1016/S0969-8043(97)00084-5",
language = "English (US)",
volume = "49",
pages = "653--655",
journal = "Applied Radiation and Isotopes",
issn = "0969-8043",
publisher = "Elsevier Limited",
number = "5-6",

}

TY - JOUR

T1 - Body composition of HIV/AIDS males

T2 - Effects of treatment with insulin- like growth factor (IGF-I) and growth hormone (GH)

AU - Ellis, K. J.

AU - Lee, Phillip

AU - Pivarnik, J. M.

AU - Bukar, J. G.

AU - Gesundheit, N.

PY - 1998/5

Y1 - 1998/5

N2 - A study was conducted to determine whether a pharmacological dose of insulin-like growth factor (IGF-I), administered with a low dose of growth hormone (GH), could produce an anabolic response in HIV/AIDS patients. The minimum effective GH dose needed, however, is not known. The GH dose selected was about an order of magnitude lower than that usually used for pharmacological treatment of GH deficiency. It was found that the moderate IGF-I dose combined with a low GH dose was insufficient to produce a detectable anabolic response as judged by the measurements of total body potassium (TBK) and total body nitrogen (TBN).

AB - A study was conducted to determine whether a pharmacological dose of insulin-like growth factor (IGF-I), administered with a low dose of growth hormone (GH), could produce an anabolic response in HIV/AIDS patients. The minimum effective GH dose needed, however, is not known. The GH dose selected was about an order of magnitude lower than that usually used for pharmacological treatment of GH deficiency. It was found that the moderate IGF-I dose combined with a low GH dose was insufficient to produce a detectable anabolic response as judged by the measurements of total body potassium (TBK) and total body nitrogen (TBN).

UR - http://www.scopus.com/inward/record.url?scp=0032079661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032079661&partnerID=8YFLogxK

U2 - 10.1016/S0969-8043(97)00084-5

DO - 10.1016/S0969-8043(97)00084-5

M3 - Article

VL - 49

SP - 653

EP - 655

JO - Applied Radiation and Isotopes

JF - Applied Radiation and Isotopes

SN - 0969-8043

IS - 5-6

ER -